Drug · DIN 02482509
KAMRAB
10 ML VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 7, 2018.
- Drug Identification Number (DIN)
- 02482509
- Company (DIN owner)
- Kamada LtdKiryat Weizmann Science Park, Rehovot, Israel
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Rabies immunoglobulin J06BB05
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RABIES IMMUNOGLOBULIN (HUMAN) | 150 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2018: NOC 21510New Drug Submission (NDS)
Other DINs named KAMRAB
- DIN 02482436 · Marketed